Literature DB >> 26223647

Vaccinia Virus B1 Kinase Is Required for Postreplicative Stages of the Viral Life Cycle in a BAF-Independent Manner in U2OS Cells.

Augusta Jamin1, Nouhou Ibrahim1, April Wicklund1, Kaitlin Weskamp2, Matthew S Wiebe3.   

Abstract

UNLABELLED: The vaccinia virus B1R gene encodes a highly conserved protein kinase that is essential for the poxviral life cycle. As demonstrated in many cell types, B1 plays a critical role during viral DNA replication when it inactivates the cellular host defense effector barrier to autointegration factor (BAF or BANF1). To better understand the role of B1 during infection, we have characterized the growth of a B1-deficient temperature-sensitive mutant virus (Cts2 virus) in U2OS osteosarcoma cells. In contrast to all other cell lines tested to date, we found that in U2OS cells, Cts2 viral DNA replication is unimpaired at the nonpermissive temperature. However, the Cts2 viral yield in these cells was reduced more than 10-fold, thus indicating that B1 is required at another stage of the vaccinia virus life cycle. Our results further suggest that the host defense function of endogenous BAF may be absent in U2OS cells but can be recovered through either overexpression of BAF or fusion of U2OS cells with mouse cells in which the antiviral function of BAF is active. Interestingly, examination of late viral proteins during Cts2 virus infection demonstrated that B1 is required for optimal processing of the L4 protein. Finally, execution point analyses as well as electron microscopy studies uncovered a role for B1 during maturation of poxviral virions. Overall, this work demonstrates that U2OS cells are a novel model system for studying the cell type-specific regulation of BAF and reveals a role for B1 beyond DNA replication during the late stages of the viral life cycle. IMPORTANCE: The most well characterized role for the vaccinia virus B1 kinase is to facilitate viral DNA replication by phosphorylating and inactivating BAF, a cellular host defense responsive to foreign DNA. Additional roles for B1 later in the viral life cycle have been postulated for decades but are difficult to examine directly due to the importance of B1 during DNA replication. Here, we demonstrate that in U2OS cells, a B1 mutant virus escapes the block in DNA replication observed in other cell types and, instead, this mutant virus exhibits impaired late protein accumulation and incomplete maturation of new virions. These data provide the clearest evidence to date that B1 is needed for multiple critical junctures in the poxviral life cycle in a manner that is both dependent on and independent of BAF.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26223647      PMCID: PMC4580198          DOI: 10.1128/JVI.01252-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Genetic Confirmation that the H5 Protein Is Required for Vaccinia Virus DNA Replication.

Authors:  Kathleen A Boyle; Matthew D Greseth; Paula Traktman
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

2.  The vaccinia virus D5 protein, which is required for DNA replication, is a nucleic acid-independent nucleoside triphosphatase.

Authors:  E Evans; N Klemperer; R Ghosh; P Traktman
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

3.  Vaccinia virus encodes an essential gene with strong homology to protein kinases.

Authors:  P Traktman; M K Anderson; R E Rempel
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

4.  Temperature-sensitive vaccinia virus mutants identify a gene with an essential role in viral replication.

Authors:  R E Rempel; M K Anderson; E Evans; P Traktman
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

5.  Vaccinia virus gene H5R encodes a protein that is phosphorylated by the multisubstrate vaccinia virus B1R protein kinase.

Authors:  G Beaud; R Beaud; D P Leader
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

6.  Genetic characterization of the vaccinia virus DNA polymerase: identification of point mutations conferring altered drug sensitivities and reduced fidelity.

Authors:  J A Taddie; P Traktman
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1.

Authors:  F Yao; P A Schaffer
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Vaccinia virus rifampicin-resistance locus specifies a late 63,000 Da gene product.

Authors:  J Tartaglia; A Piccini; E Paoletti
Journal:  Virology       Date:  1986-04-15       Impact factor: 3.616

9.  Vaccinia virus core protein VP8 is required for virus infectivity, but not for core protein processing or for INV and EEV formation.

Authors:  D Wilcock; G L Smith
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

10.  Proteolytic maturation of vaccinia virus core proteins: identification of a conserved motif at the N termini of the 4b and 25K virion proteins.

Authors:  J K VanSlyke; C A Franke; D E Hruby
Journal:  J Gen Virol       Date:  1991-02       Impact factor: 3.891

View more
  4 in total

1.  The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12.

Authors:  Amber B Rico; Zhigang Wang; Annabel T Olson; Alexandria C Linville; Brianna L Bullard; Eric A Weaver; Clinton Jones; Matthew S Wiebe
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

2.  Identification of Vaccinia Virus Replisome and Transcriptome Proteins by Isolation of Proteins on Nascent DNA Coupled with Mass Spectrometry.

Authors:  Tatiana G Senkevich; George C Katsafanas; Andrea Weisberg; Lisa R Olano; Bernard Moss
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

3.  Deletion of the Vaccinia Virus B1 Kinase Reveals Essential Functions of This Enzyme Complemented Partly by the Homologous Cellular Kinase VRK2.

Authors:  Annabel T Olson; Amber B Rico; Zhigang Wang; Gustavo Delhon; Matthew S Wiebe
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

4.  The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.

Authors:  Amber B Rico; Alexandria C Linville; Annabel T Olson; Zhigang Wang; Matthew S Wiebe
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.